共 50 条
Iron deficiency and anemia in oncology
被引:1
|作者:
Scotte, Florian
[1
]
Launay-Vacher, Vincent
[2
]
Ray-Coquard, Isabelle
[3
]
机构:
[1] Hop Europeen Georges Pompidou, Med Oncol Serv, F-75015 Paris, France
[2] Hop La Pitie Salpetriere, Serv ICAR, F-75013 Paris, France
[3] Ctr Leon Berard, Med Oncol Serv, F-69373 Lyon, France
关键词:
anaemia;
cancer;
iron;
iron deficiency;
supportive care;
QUALITY-OF-LIFE;
CHEMOTHERAPY-RELATED ANEMIA;
LUNG-CANCER PATIENTS;
EPOETIN-ALPHA;
INTRAVENOUS IRON;
DARBEPOETIN ALPHA;
DOUBLE-BLIND;
EORTC GUIDELINES;
TRIAL;
ERYTHROPOIETIN;
D O I:
10.1684/bdc.2012.1579
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Anemia in oncology is no longer seen only as a side effect of chemotherapies. This comorbidity may be multifactorial, clinically and, for example, may be rather chronic when the patient has chronic renal failure associated, resulting in renal anemia. Similarly, the presence of iron deficiency, which can be solely responsible or contributing factor of anemia, is also a factor to be taken into account in both the diagnosis and exploration of anemia and in its treatment, requiring the use of injectable iron complexes for treatment, if necessary in combination with an erythropoiesis agent stimulating.
引用
收藏
页码:563 / 570
页数:8
相关论文